Multiomics Tumor Evolution Model of NSCLC — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Multiomics Tumor Evolution Model of NSCLC — Stella

Home/Non-small Cell Lung Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Non-small Cell Lung Cancer trials

Trial locations(1 site)

China

Peking University People's Hospital, Beijing

Key details

Sponsor

Peking University People's Hospital

Collaborators

Research Unit of Intelligence Diagnosis and treatment of early-stage non-small cell lung cancer, Chinese Academy of Medical Sciences

Enrollment target

~300 participants

Started

April 2022

Primary completion

December 2026

Age range

18 Years and older

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.